Vasculitis (plural: vasculitides) is an umbrella term for a diverse group of clinicopathologic syndromes characterized by inflammation of the blood vessels (arteries, veins, and capillaries). The inflammatory process involves the infiltration of immune cells (such as neutrophils, lymphocytes, and macrophages) into the vessel wall, which causes structural damage. This can result in vessel thickening and narrowing (leading to tissue ischemia), or vessel wall weakening (leading to aneurysm formation or hemorrhage). Clinically, vasculitides are typically classified by the size of the predominant vessels affected: Large-vessel vasculitis (e.g., Giant Cell Arteritis [GCA], Takayasu arteritis) affects the aorta and its major branches; Medium-vessel vasculitis (e.g., Polyarteritis Nodosa [PAN], Kawasaki disease) affects main visceral arteries; and Small-vessel vasculitis (e.g., ANCA-associated vasculitides like Granulomatosis with polyangiitis [GPA], microscopic polyangiitis) affects arterioles, capillaries, and venules, often manifesting with palpable purpura, glomerulonephritis, and pulmonary hemorrhage. Clinical Indicators: For coding and documentation, coders must look for the specific named syndrome (e.g., “Wegener’s”, “Kawasaki”, “Giant Cell”), the size of the vessels involved, the presence of specific autoantibodies (e.g., c-ANCA, p-ANCA), and critically, any specific organ involvement (e.g., renal failure, pulmonary hemorrhage, neuropathy), as systemic complications often drive code selection and DRG assignment.
“Small vessel / blood vessel” — referring to the anatomical structures that carry blood throughout the body; appears in vascular, cardiovascular, vasculopathy
“Inflammation of / disease of” — the universal medical suffix for inflammatory processes; appears in arthritis, dermatitis, appendicitis
Literally: “Inflammation of a blood vessel.” The term is synonymous with angiitis (from the Greek angeion, meaning vessel), though vasculitis is the overwhelmingly preferred term in modern clinical and diagnostic classifications (such as the Chapel Hill Consensus Conference definitions). When specifying the type of vessel, terms like arteritis (arteries) and venulitis or phlebitis (veins) are utilized.
Arteritis(inflammation specifically of the arteries; e.g., Giant Cell Arteritis)
Venulitis / Phlebitis(inflammation specifically of the veins or venules)
ANCA-associated vasculitis (AAV)(group of small-vessel vasculitides driven by anti-neutrophil cytoplasmic antibodies)
Hypersensitivity angiitis(older term often referring to cutaneous small-vessel vasculitis triggered by a drug or infection)
Necrotizing vasculopathy(a severe form of vasculitis where the inflammation causes fibrinoid necrosis of the vessel wall)
🔗 RELATED TERMS
Giant cell arteritis (GCA) — M31.6; the most common form of systemic vasculitis in adults over 50, primarily affecting branches of the carotid artery (e.g., temporal artery); can cause irreversible blindness.
Polymyalgia rheumatica (PMR) — M35.3; an inflammatory disorder causing severe muscle stiffness in the shoulders and hips, heavily associated and frequently co-occurring with GCA.
Granulomatosis with polyangiitis (GPA) — M31.30; formerly Wegener’s granulomatosis; a severe ANCA-associated small-vessel vasculitis classically affecting the upper/lower respiratory tracts and kidneys.
Kawasaki disease — M30.3; an acute, self-limiting medium-vessel vasculitis primarily affecting young children, with a high risk of coronary artery aneurysms.
Polyarteritis nodosa (PAN) — M30.0; a systemic necrotizing inflammation of medium-sized arteries, often associated with Hepatitis B infection, sparing the lungs.
Purpura — D69.2 (Other nonthrombocytopenic purpura); a classic dermatologic sign of small-vessel vasculitis resulting from red blood cells leaking into the skin from damaged capillaries.
Erythrocyte sedimentation rate (ESR) — a common, non-specific blood marker of systemic inflammation that is typically highly elevated in systemic vasculitides like GCA.
Aneurysm — a localized, blood-filled balloon-like bulge in the wall of a blood vessel; a frequent complication of vessel wall damage in medium and large-vessel vasculitis.
(⚠️ ICD-10-CM coding for vasculitis is highly specific to the underlying syndrome, the size of the vessels, and organ involvement. “Unspecified vasculitis” fragments into multiple chapters based on the assumed site.)
Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion (Commonly used to biopsy palpable purpura to confirm leukocytoclastic small-vessel vasculitis)
Level IV - Surgical pathology, gross and microscopic examination (Billed by the pathologist reviewing the skin/temporal artery biopsy for immune infiltration)
Bilateral procedure — Used if bilateral temporal artery biopsies are performed during the same operative session to maximize the chance of capturing a “skip lesion”.
Professional component — Append to pathology or lab codes (88305) if the physician is interpreting the results but the facility owns the lab equipment.
⚠️ Coding Note: The most frequent clinical documentation error regarding vasculitis is failing to specify the syndrome or organ involvement. If a chart simply says “vasculitis,” coders are forced to index it based on context, which often defaults to the vague I77.6 or L95.9. Always query the provider for the specific type (e.g., GPA, PAN, GCA). Furthermore, for conditions like Granulomatosis with polyangiitis (GPA), you must explicitly check for renal (kidney) involvement. If a rheumatologist or nephrologist notes that the patient’s creatinine is elevated or they have glomerulonephritis due to GPA, you must code M31.31 (with renal involvement), which carries a significantly higher risk adjustment (HCC) value than M31.30. Additionally, when a patient presents with both Giant Cell Arteritis and Polymyalgia Rheumatica, do not code them separately; ICD-10-CM requires the combination code M31.5.
Crystal's MCW Coder Hub